Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses
Clinical trial NCT03021317 · TERMINATED
Trial details
- NCT number
- NCT03021317
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2020-10-07
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.